Phase I trial of escalating doses of ABI-007 (nanoparticle albumin-bound paclitaxel) and gemcitabine in patients (pts) with thoracic malignancies

被引：0
|
作者：
Lee, C. B.
Stinchcombe, T. E.
Socinski, M. A.
Hayes, D. N.
Goldberg, R. M.
Hawkins, M. J.
Obasaju, C. K.
Dees, E. C.
机构：
[1] Univ N Carolina, Chapel Hill, NC 27515 USA
[2] Abraxis Oncol, Los Angeles, CA USA
[3] Lilly Oncol, Indianapolis, IN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
18094
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Phase I trial of nanoparticle albumin-bound paclitaxel in combination with gemcitabine in patients with thoracic malignancies
    Stinchcombe, Thomas E.
    Socinski, Mark A.
    Lee, Carrie B.
    Hayes, D. Neil
    Moore, Dominic T.
    Goldberg, Richard M.
    Dees, E. Claire
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (05) : 521 - 526
  • [2] ABI-007, nanoparticle albumin-bound paclitaxel, enhances tumor radioresponse.
    Mason, Kathy A.
    Wiedenmann, Nicole
    Valdecanas, David
    Buchholz, Thomas
    Milas, Luka
    CANCER RESEARCH, 2006, 66 (08)
  • [3] In vivo radiation enhancement by ABI-007, a nanoparticle albumin-bound (nab) paclitaxel
    Wiedenmann, N.
    Valdecanas, D.
    Farrar, D.
    Milas, L.
    Mason, K.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2006, 182 : 13 - 14
  • [4] Multicenter phase II trial of ABI-007, an albumin-bound paclitaxel, in women with metastatic breast cancer
    Ibrahim, NK
    Samuels, B
    Page, R
    Doval, D
    Patel, KM
    Rao, SC
    Nair, MK
    Bhar, P
    Desai, N
    Hortobagyi, GN
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) : 6019 - 6026
  • [5] Phase I and pharmacokinetic trial of carboplatin and albumin-bound paclitaxel, ABI-007 (Abraxane®) on three treatment schedules in patients with solid tumors
    Stinchcombe, Thomas E.
    Socinski, Mark A.
    Walko, Christine M.
    O'Neil, Bert H.
    Collichio, Frances A.
    Ivanova, Anastasia
    Mu, Hua
    Hawkins, Michael J.
    Goldberg, Richard M.
    Lindley, Celeste
    Dees, E. Claire
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (05) : 759 - 766
  • [6] Phase I and pharmacokinetic trial of carboplatin and albumin-bound paclitaxel, ABI-007 (Abraxane®) on three treatment schedules in patients with solid tumors
    Thomas E. Stinchcombe
    Mark A. Socinski
    Christine M. Walko
    Bert H. O’Neil
    Frances A. Collichio
    Anastasia Ivanova
    Hua Mu
    Michael J. Hawkins
    Richard M. Goldberg
    Celeste Lindley
    E. Claire Dees
    Cancer Chemotherapy and Pharmacology, 2007, 60 : 759 - 766
  • [7] Phase I and pharmacokinetics trial of ABI-007, a novel nanoparticle formulation of paclitaxel in patients with advanced nonhematologic malignancies
    Nyman, DW
    Campbell, KJ
    Hersh, E
    Long, K
    Richardson, K
    Trieu, V
    Desai, N
    Hawkins, MJ
    Von Hoff, DD
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (31) : 7785 - 7793
  • [8] Albumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancer
    Miele, Evelina
    Spinelli, Gian Paolo
    Miele, Ermanno
    Tomao, Federica
    Tomao, Silverio
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2009, 4 (01): : 99 - 105
  • [9] A phase I trial of ABI-007, nanoparticle paclitaxel, administered to patients with advanced non-hematologic malignancies.
    Nyman, DW
    Campbell, KJ
    Hersh, E
    Richardson, K
    Patrick, K
    Trieu, V
    Desai, N
    Von Hoff, DD
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 133S - 133S
  • [10] Combined modality treatment with ABI-007, nanoparticle albumin-bound (nab) paclitaxel:: modification of radiation response in vivo
    Wiedenmann, N.
    Valdecanas, D.
    Hunter, N.
    Farrar, D.
    Milas, L.
    Mason, K.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2007, 183 : 97 - 97
12345